Compile Data Set for Download or QSAR
Report error Found 266 Enz. Inhib. hit(s) with all data for entry = 11943
TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663088(US20240109898, Compound Z-15)
Affinity DataIC50: 5nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663099(US20240109898, Compound Z-26-P1)
Affinity DataIC50: 5nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663075(US20240109898, Compound Z-2)
Affinity DataIC50: 6nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663105(US20240109898, Compound Z-28-P1)
Affinity DataIC50: 6nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663115(US20240109898, Compound Z-33)
Affinity DataIC50: 6nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663118(US20240109898, Compound Z-36)
Affinity DataIC50: 6nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663078(US20240109898, Compound Z-5 | US20240109898, Compo...)
Affinity DataIC50: 7nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663081(US20240109898, Compound Z-9)
Affinity DataIC50: 8nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663103(US20240109898, Compound Z-27-P2)
Affinity DataIC50: 8nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663101(US20240109898, Compound Z-27)
Affinity DataIC50: 9nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663112(US20240109898, Compound Z-32)
Affinity DataIC50: 9nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663108(US20240109898, Compound Z-30)
Affinity DataIC50: 10nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663109(US20240109898, Compound Z-30-P1)
Affinity DataIC50: 10nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663130(US20240109898, Compound Z-46)
Affinity DataIC50: 10nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663146(US20240109898, Compound Z-62-P1)
Affinity DataIC50: 10nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663104(US20240109898, Compound Z-28)
Affinity DataIC50: 11nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663107(US20240109898, Compound Z-29)
Affinity DataIC50: 11nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663151(US20240109898, Compound Z-64-P2)
Affinity DataIC50: 11nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663083(US20240109898, Compound Z-11-P1)
Affinity DataIC50: 12nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663106(US20240109898, Compound Z-28-P2)
Affinity DataIC50: 12nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663095(US20240109898, Compound Z-22)
Affinity DataIC50: 13nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663126(US20240109898, Compound Z-41-P2)
Affinity DataIC50: 13nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663140(US20240109898, Compound Z-56)
Affinity DataIC50: 13nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663077(US20240109898, Compound Z-4)
Affinity DataIC50: 14nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663148(US20240109898, Compound Z-63)
Affinity DataIC50: 14nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663139(US20240109898, Compound Z-55)
Affinity DataIC50: 15nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663149(US20240109898, Compound Z-64 | US20240109898, Comp...)
Affinity DataIC50: 15nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663122(US20240109898, Compound Z-38-P2)
Affinity DataIC50: 16nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663138(US20240109898, Compound Z-54)
Affinity DataIC50: 16nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663078(US20240109898, Compound Z-5 | US20240109898, Compo...)
Affinity DataIC50: 17nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663120(US20240109898, Compound Z-38)
Affinity DataIC50: 17nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663145(US20240109898, Compound Z-62)
Affinity DataIC50: 17nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663074(US20240109898, Compound Z-1)
Affinity DataIC50: 18nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663086(US20240109898, Compound Z-13)
Affinity DataIC50: 18nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663117(US20240109898, Compound Z-35)
Affinity DataIC50: 18nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663144(US20240109898, Compound Z-61 | US20240109898, Comp...)
Affinity DataIC50: 18nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663160(US20240109898, Compound Z-73)
Affinity DataIC50: 18nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663152(US20240109898, Compound Z-65)
Affinity DataIC50: 19nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663085(US20240109898, Compound Z-12)
Affinity DataIC50: 20nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663142(US20240109898, Compound Z-58)
Affinity DataIC50: 20nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663159(US20240109898, Compound Z-72)
Affinity DataIC50: 20nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663097(US20240109898, Compound Z-25)
Affinity DataIC50: 21nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663082(US20240109898, Compound Z-11)
Affinity DataIC50: 22nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663089(US20240109898, Compound Z-16)
Affinity DataIC50: 22nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663110(US20240109898, Compound Z-30-P2)
Affinity DataIC50: 22nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663127(US20240109898, Compound Z-42 | US20240109898, Comp...)
Affinity DataIC50: 22nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663078(US20240109898, Compound Z-5 | US20240109898, Compo...)
Affinity DataIC50: 23nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663127(US20240109898, Compound Z-42 | US20240109898, Comp...)
Affinity DataIC50: 23nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663143(US20240109898, Compound Z-60)
Affinity DataIC50: 24nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663147(US20240109898, Compound Z-62-P2)
Affinity DataIC50: 24nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

Displayed 1 to 50 (of 266 total ) | Next | Last >>
Jump to: